EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker

Hadis Moradbaki, Hanieh Hassani-Pajooh, Mohammad-Amin Valizade-Hasanloei, Shima Hatamkhani, Kiumarth Amini, Maryam Zamanirafe, Maryam Mehrpooya, Abbas Taher

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04526-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Hadis Moradbaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran. Hauptthemen laut MEDLINE: Ubiquinone, Oxidative Stress, Shock, Septic, Antioxidants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquinoneOxidative StressShock, SepticAntioxidantsOrganophosphorus CompoundsHumansPilot ProjectsMaleFemaleMiddle AgedBiomarkersDouble-Blind MethodAgedTreatment OutcomeOrgan Dysfunction Scores

Stichwörter der Autor:innen

MitoQMitochondria-targeted antioxidantsOxidative stressSeptic shock

Substanzen

UbiquinoneBiomarkersmitoquinoneAntioxidantsOrganophosphorus Compounds

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran.
  • Clinical Research Institute, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Clinical Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
  • Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran. m_mehrpooya2003@yahoo.com.
  • Department of Anesthesiology and Critical Care, School of Medicine, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran. bsstaher@gmail.com.

Zitieren

APA

Moradbaki, H., Hassani-Pajooh, H., Valizade-Hasanloei, M. A., Hatamkhani, S., Amini, K., Zamanirafe, M., Mehrpooya, M., & Taher, A. (2026). A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04526-9

Vancouver

Moradbaki H, Hassani-Pajooh H, Valizade-Hasanloei MA, Hatamkhani S, Amini K, Zamanirafe M, et al. A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04526-9

BibTeX
@article{Moradbaki2026,
  author = {Moradbaki, Hadis and Hassani-Pajooh, Hanieh and Valizade-Hasanloei, Mohammad-Amin and Hatamkhani, Shima and Amini, Kiumarth and Zamanirafe, Maryam and Mehrpooya, Maryam and Taher, Abbas},
  title = {A pilot double-blind, placebo-controlled, randomized clinical trial of MitoQ in the treatment of septic shock: evaluating its effects on clinical outcomes and oxidative stress biomarker},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04526-9}
}
Kostenlos starten →